drug information

2 immunotherapy treatments in the news: Imfinzi and Keytruda update

1 Comment / Cancer, Conditions, Patient Experiences, Research / By

Two immunotherapy treatments — Imfinzi (durvalumab) and Keytruda (pembrolizumab) — have made headlines recently in relation to lung cancer treatment. What’s the latest? Here’s an update. Expanded FDA approval for Imfinzi The U.S. Food and Drug Administration (FDA) first approved Imfinzi as a bladder cancer treatment in 2017. Imfinzi is marketed by AstraZeneca. In February 2018, the FDA approved […]

2 immunotherapy treatments in the news: Imfinzi and Keytruda update Read More »

Want to know more about Radicava (edaravone)? Here’s a snapshot:

2 Comments / ALS, Patient Experiences, Research / By

With the recent FDA approval of Radicava (edaravone), we wanted to know more about how it works and what it means for patients living with ALS. We asked Maria Lowe, Pharm.D., BCPS, and our Health Data Integrity team, to give us a snapshot of the drug, how it’s used and what you should know. Maria’s rundown

Want to know more about Radicava (edaravone)? Here’s a snapshot: Read More »

A Day in the Life of Health Data and Drug Information Clinical Specialist David Blaser

Patient Experiences, Research / By

What’s it like to work at PatientsLikeMe?  We are continuing to reveal just that with our ongoing blog series “A Day in the Life,” which features PatientsLikeMe employees from different departments.  Today we’d like to introduce you to David Blaser, PharmD, a registered pharmacist who decided to trade his white lab coat for the more casual

A Day in the Life of Health Data and Drug Information Clinical Specialist David Blaser Read More »

Scroll to Top